Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index; 1 of the 25 sources its claims cite were checked for support.

Distribution and characteristics of malignant tumours by lung lobe

Open access

Abstract

The aim of this study was to investigate the distribution and characteristics of malignant tumours between the lung lobes and whether the diagnosis, treatment, and outcome differed based on location. This study is based on 10,849 lung cancer patients diagnosed in 2018-2022 with complete data on the location and characteristics of the tumours. The proportions of tumours in each lobe divided by its volume were termed the relative proportion. The right upper lobe comprised 31.2% of the tumours and 17.6% of the lung volume. The relative proportion of 1.77 was higher than in the other lobes (p < 0.001). After adjusting for age, sex, stage, and histology, the location of the tumour was found to be a significant independent predictor for resection but not for survival. CONCLUSION: The main finding of the right upper lobe as a site of predilection for lung cancer is similar to tuberculosis and pneumoconiosis. This may be explained that most of the inhaled air, containing bacilli, inorganic particles or tobacco smoke, is distributed to the upper lobes.

Overview

CoChat Summary

TL;DR

Using national Norwegian registry data on 10,849 lung cancer patients diagnosed in 2018–2022, the study found that malignant tumours were not evenly distributed across lung lobes, with the right upper lobe showing the highest relative proportion (1.77). Lobe location was associated with diagnosis and treatment patterns, but not with survival after adjustment.

Key findings

  • In 10,849 eligible patients, the right upper lobe (RUL) contained 31.2% of tumours but only 17.6% of lung volume, giving the highest relative proportion of 1.77 (p < 0.001).
  • The right middle lobe (RML) had the lowest relative proportion of tumours (0.64) but the highest proportion of neuroendocrine tumours: 26.1% versus 15.3% on average.
  • Tumours in the upper lobes were more often treated with curative radiotherapy (20.1% vs. 18.3% in lower lobes), while surgical resection was more common in lower lobes (30.4% vs. 27.8%; p < 0.001).
  • After adjustment for age, sex, stage, histology, and EGFR status, lobe location was an independent predictor of resection but not of survival; the study reported 5-year relative survival of 33.7%.

Methods

  • Population-based registry study using Cancer Registry of Norway data, restricted to lung cancer patients diagnosed in 2018–2022 with complete data on tumour location and characteristics.
  • Final analytic sample: 10,849 patients; analyses used complete-case data for most results, with multiple imputation in logistic and Cox regression models for missing side/lobe, histology, cTNM, and EGFR data.
  • Main analyses included descriptive comparisons by lobe, relative proportions of tumours by lobe volume, logistic regression for surgery, and Cox regression for survival, adjusted for age, sex, stage, histology, EGFR status, and first treatment.

Limitations

  • The paper states limitations of missing information on smoking, performance status, and socioeconomic status, and that the study is retrospective.
  • The volume reference used to calculate relative proportions came from Yamada et al.’s healthy volunteers in another population, not Nordic volunteers; the paper notes the variation was low, but this remains a potential limitation.
  • Evident from the text: patients with tumours in the main bronchus, overlapping lesions, unknown location, or incomplete diagnostic data were excluded, so findings may not generalize to all lung cancer patients.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1186/s12890-024-02918-w

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 The relative proportion of all malignant tumours (left panel) and the proportion of the subgroup with neuroendocrine tumours by lung lobe (right panel) among patients diagnosed with lung cancer 2018–2022 in Norway. The dashed lines indicate the level if all tumours and subgroups were evenly distributed within the lung. Abbreviations: LLL: left lower lobe, LUL: left upper lobe, RLL: right lower lobe, RML: right middle lobe RUL: right upper lobe
Fig. 1 The relative proportion of all malignant tumours (left panel) and the proportion of the subgroup with neuroendocrine tumours by lung lobe (right panel) among patients diagnosed with lung cancer 2018–2022 in Norway. The dashed lines indicate the level if all tumours and subgroups were evenly distributed within the lung. Abbreviations: LLL: left lower lobe, LUL: left upper lobe, RLL: right lower lobe, RML: right middle lobe RUL: right upper lobeCC BY · PubMed Central

Verification

Claims the paper makes

1 Valid · 0 Not valid · 11 Not checked · 50 Own results and interpretations

25 more claims

Create a free account to see all 62 claims and to verify the 3 references still open.

See all claims — free account
  • It may state two separate claims as one. 27
  • Probably not a substantial claim. 7
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Citations

Cites

Show all 25 references

Research works printed but not linked: 3

  1. Corryn B, Nicholoson A. Pathology Og the lungs. 3rd ed. Churchill Livingston Elsevier; 2011.
  2. Liavaag K. Bronchiogenic Carcinoma. Acta Chir Scand. 1949;98:182–204.
  3. Kumar. V, Abbas. A. J A: Robbins Basic Pathology. 10th ed. Elsevier; 2017.

Cited by

See all 11

Metadata

Authors
Nilssen, Y., Brustugun, O. T., Fjellbirkeland, L., Helland, Å., Møller, B., Wahl, S. G. F., & Solberg, S.
Affiliations
  • Cancer Registry of Norway (NO)
  • University of Oslo (NO)
  • Oslo University Hospital (NO)
  • St Olav's University Hospital (NO)
Corresponding author
Solberg, Steinar
Venue
BMC Pulmonary Medicine
Published
2024-03-04
Volume
24
Issue
1
Pages
106-106
ISSN
1471-2466 (ISSN-L)
OpenAlex
W4392376331
Cited by
11
References
25
Citations by year
2026: 5 · 2025: 5 · 2024: 1
FWCI
3.17
Type
journal article
Language
en
Open access
Licence
Locations
  • BMC Pulmonary Medicine (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • NORA - Norwegian Open Research Archives (submittedVersion, cc-by)
Funders
University of Oslo
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Lung Cancer Diagnosis and Treatment
  • Health Sciences › Medicine › Oncology › Lung Cancer Research Studies
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
Keywords
lung cancer, tumor location, lung lobes, right upper lobe, neuroendocrine tumors, surgical resection, definitive radiotherapy, survival, histology, tobacco smoke, inhaled particles
MeSH terms
Humans, Lung, Lung Neoplasms, Neuroendocrine Tumors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Distribution and characteristics of malignant tumours by lung lobe. https://app.cochat.ai/papers/10.1186/s12890-024-02918-w
The paper
Nilssen, Y., Brustugun, O. T., Fjellbirkeland, L., Helland, Å., Møller, B., Wahl, S. G. F., & Solberg, S. (2024). Distribution and characteristics of malignant tumours by lung lobe. BMC Pulmonary Medicine. https://doi.org/10.1186/s12890-024-02918-w

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.